A randomized trial found that the use of UV-C machines can cut transmission of four major superbugs by a cumulative 30 percent, according to an article on the Infection Control Today website.
The study was led by Duke Health and published in The Lancet. Its results are specific to patients who stay overnight in a room where someone with a known positive culture or infection of a drug-resistant organism had previously been treated.
The researchers focused on: MRSA, vancomycin-resistant enterococci (VRE), C. difficile and Acinetobacter.
The facilities studied used a portable machine called the Tru-D SmartUV-C to disinfect rooms where patients with the target bacteria had been staying.
How Retail Design Can Improve the Healthcare Patient Experience
Jefferson Health Breaks Ground on Lehigh Valley Hospital—Coopersburg
Encompass Health Plans Second Small-Format Rehabilitation Hospital
Rethinking How Healthcare Facilities Fund Construction Projects
Winners Named for the 15th Annual Healthcare Design Awards